US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist

30.155
+0.165+0.55%

Trading Nov 21 13:16 ET

3.07BMarket Cap-8423P/E (TTM)

Dyne Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dyne Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Dyne Therapeutics Earnings Reports

Dyne Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12 13:07 ET

Dyne Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12 17:07 ET

Dyne Therapeutics | 10-Q: Q1 2024 Earnings Report

May 2 17:12 ET

Dyne Therapeutics | 10-K: FY2023 Annual Report

Mar 5 07:37 ET

Analyst Rating

Updated: Nov 16, 2024

Strong Buy

Buy
85.71%
Hold
14.29%
Sell
0.00%

Price Target

No Data

Heat List

Overall